Cells contain helper molecules called transfer RNAs (tRNAs), which carry building blocks (amino acids) to make proteins.

Guoping Li, Ph.D., of the Department of Anesthesia, Critical Care & Pain Medicine at Massachusetts General Hospital, is the ...

Kidneys are important organs that work by filtering waste and excess fluids from our body. However, when they begin to ...

Personalised care in conservative kidney management (CKM) provides person-centred care for patients who have opted for ...

Guoping Li, PhD, of the Department of Anesthesia, Critical Care & Pain Medicine at Massachusetts General Hospital, is the lead author and Saumya Das, MD, PhD, of the Cardiovascular Research Center at ...

The single mom is urgently seeking a kidney donor and has turned her car into a mobile plea, listing her blood type and contact info.

Mismatches in an immune cell surface receptor could contribute to higher transplant rejection rates, a new study finds.

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.

The heart and kidneys are intricately connected, with the health of one impacting the other. Kidney disease increases the risk of cardiovascular complications, often proving fatal. Early detection and ...

E-Poster No. 1325 About Akebia Therapeutics Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease.

CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, ...